Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/04
End: 12/31/05
Due: 12/31/06
Phase: N/A
Priority: Normal
Start: 04/28/17
End: 04/24/19
Due: 04/24/20
Phase: N/A
Priority: Normal
Start: 10/31/06
End: 10/31/08
Due: 10/31/09
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| The Effect of a Probiotic on Hepatic Steatosis | NCT00099723 | VSL Pharmaceuticals | user2@example.com | None | 2004-10-31 | 2005-12-31 | 2006-12-31 | - | - | 2025-07-14 |
| PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis | NCT03415711 | VSL Pharmaceuticals | user2@example.com | None | 2017-04-28 | 2019-04-24 | 2020-04-24 | - | - | 2025-07-14 |
| Food Supplementation With VSL#3 as a Support to Standard Pharmaceutical Therapy in Ulcerative Colitis | NCT00951548 | VSL Pharmaceuticals | user2@example.com | None | 2006-10-31 | 2008-10-31 | 2009-10-31 | - | - | 2025-07-14 |